Patients treated on trolleys in corridors and in ambulances parked outside emergency departments have become the visual shorthand for an NHS under strain. Into that setting arrives the government's evidence to the doctors' pay review body, which proposes a 2.4 per cent uplift for 2027/28. The British Medical Association calls it a pay cut and unions have called it derisory. Whatever one makes of the language, the number has landed at a moment when the service can least afford a fresh argument with its most expensive and most mobile workforce.

The arithmetic offered by the Department of Health and Social Care and NHS England is instructive. Each 0.5 per cent on pay costs roughly £750 million, which the submission equates to more than 89,000 hip or knee replacements. That is a deliberate framing, because elective waiting times are the measure by which ministers have chosen to be judged. Yet the same evidence says the uplift can be planned without trade-offs against headline commitments. Both statements cannot carry equal weight. If 2.4 per cent is affordable without consequences, the operations comparison is rhetorical. If the comparison is sincere, there are consequences, and the Department should say where they fall.

Precedent suggests the opening offer is a position rather than a conclusion. In 2026 the government began at 2.5 per cent, the review body recommended 3.5 per cent, and ministers accepted it. The BMA now says the review body faces a test of its independence. That is a fair description of the risk. If the body recommends well above the government's figure again, the process begins to look like a ritual in which the evidence is written to be overruled. If it falls into line with a number set by the Treasury, doctors will conclude that independence was nominal, and the next dispute will begin with less faith in the machinery designed to prevent one.

The industrial relations picture makes that outcome more dangerous. Some groups of doctors are already in dispute, and consultants in England hold a mandate for strike action. Every day of lost elective activity works directly against the waiting list recovery that the restraint on pay is meant to protect. A serious accounting would set the £750 million figure beside the cost of cancelled lists, rescheduled outpatient clinics and the managerial time consumed by contingency planning. The submission quoted so far does not attempt that comparison, and it should.

Retention is the slower pressure. The BMA argues that doctors' pay is well below its level twenty years ago, and the claim is consistent with the way the profession talks about itself. Employers cannot easily test it, but they can observe the consequences in rota gaps, locum spending and the reluctance of trainees to commit to posts in England. Alongside this sits the union argument that policymakers are attempting to substitute non-medical staff for doctors on the cheap. One need not accept that characterisation in full to see that a thin pay offer strengthens it. Workforce reform that is read as cost cutting will meet resistance regardless of its clinical merits.

Wider NHS pay compounds the difficulty. Unison reports that more than 200,000 NHS staff earn less than the real living wage. A settlement for doctors reverberates across other pay review bodies and across Agenda for Change, so the government is negotiating with the whole health workforce at once, even if the formal process is divided.

For NHS leaders the practical issue is funding. Trusts and integrated care boards will plan 2027/28 on whatever pay assumption the centre sets. If the final settlement exceeds 2.4 per cent and the difference is not funded, the shortfall lands on providers already managing energy costs, inflation and falling immigration health surcharge income. Leaders should press now for clarity on who carries that risk. Policymakers have a narrower task, which is to decide whether the review body is a genuine instrument or a formality, and to behave accordingly.

The waiting list pledge depends on the doctors the offer asks to accept real-terms restraint. A government that wants one outcome while undervaluing the means of achieving it will find the gap between promise and delivery widening, and patients will measure it in corridors.

‍